[go: up one dir, main page]

CO2022010461A2 - Composición para usar en el tratamiento de trastornos cognitivos - Google Patents

Composición para usar en el tratamiento de trastornos cognitivos

Info

Publication number
CO2022010461A2
CO2022010461A2 CONC2022/0010461A CO2022010461A CO2022010461A2 CO 2022010461 A2 CO2022010461 A2 CO 2022010461A2 CO 2022010461 A CO2022010461 A CO 2022010461A CO 2022010461 A2 CO2022010461 A2 CO 2022010461A2
Authority
CO
Colombia
Prior art keywords
treatment
cognitive disorders
composition
compositions
contain
Prior art date
Application number
CONC2022/0010461A
Other languages
English (en)
Spanish (es)
Inventor
Martín Mónica María Olivares
Lliberia Mercè Pallàs
Ferre Cristian Gaspar Griñan
Martínez Luís Pérez
Larramendi José Luis López
Hortigüela Óscar Bañuelos
Original Assignee
Biosearch S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch S A filed Critical Biosearch S A
Publication of CO2022010461A2 publication Critical patent/CO2022010461A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/745Polymers of hydrocarbons
    • A61K31/75Polymers of hydrocarbons of ethene
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/18Lipids
    • A23V2250/186Fatty acids
    • A23V2250/1868Docosahexaenoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CONC2022/0010461A 2020-01-03 2022-07-26 Composición para usar en el tratamiento de trastornos cognitivos CO2022010461A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES2020070005 2020-01-03
PCT/EP2021/050270 WO2021136848A1 (fr) 2020-01-03 2021-01-08 Composition destinée à être utilisée dans le traitement de troubles cognitifs

Publications (1)

Publication Number Publication Date
CO2022010461A2 true CO2022010461A2 (es) 2022-08-09

Family

ID=69941402

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0010461A CO2022010461A2 (es) 2020-01-03 2022-07-26 Composición para usar en el tratamiento de trastornos cognitivos

Country Status (9)

Country Link
EP (1) EP4084787A1 (fr)
JP (1) JP7655920B2 (fr)
KR (1) KR20220123272A (fr)
CN (1) CN115066237A (fr)
AU (1) AU2021204964A1 (fr)
BR (1) BR112022013296A2 (fr)
CO (1) CO2022010461A2 (fr)
MX (1) MX2022008258A (fr)
WO (1) WO2021136848A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115944729A (zh) * 2023-02-10 2023-04-11 中国药科大学 热疗组合物、药物组合物及其制备方法和应用
IT202300023586A1 (it) * 2023-11-08 2025-05-08 Hope S R L Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540884A (en) 1982-12-29 1985-09-10 Finnigan Corporation Method of mass analyzing a sample by use of a quadrupole ion trap
US5397894A (en) 1993-05-28 1995-03-14 Varian Associates, Inc. Method of high mass resolution scanning of an ion trap mass spectrometer
JP3415198B2 (ja) * 1993-06-30 2003-06-09 三省製薬株式会社 皮膚外用剤
US7112609B2 (en) 1999-06-01 2006-09-26 Drugtech Corporation Nutritional supplements
US6258846B1 (en) 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
ES2179767B1 (es) 2001-03-16 2004-05-16 Compañia General Del Algarrobo De España, S.A. Procedimiento para la obtencion de pinitol a partir de extractos de algarroba.
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
EP1559430B1 (fr) * 2004-01-29 2009-04-15 INDENA S.p.A. Utilisation de complexes de Ginkgo pour l'augmentation des fonctions cognitives et l'appaisement de la fatigue mentale
US8193250B2 (en) 2004-10-22 2012-06-05 Mount Sinai School Of Medicine Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system
US20070032548A1 (en) 2005-07-08 2007-02-08 Ellis Lorie A Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
HUE041715T2 (hu) * 2007-12-21 2019-05-28 Dr Willmar Schwabe Gmbh & Co Kg Ginkgo biloba levél-kivonat alkalmazása
EP2087900A1 (fr) * 2008-02-07 2009-08-12 Velleja Research SRL Extrait de Ginkgo biloba avec un contenu de flavonoïde du ginkgo standardisé privé de la fraction terpénique à antagoniste paf, et compositions le contenant, pour la prévention et le traitement des troubles circulatoires, cognitifs, gériatriques et sensoriels
JP5610736B2 (ja) 2009-10-06 2014-10-22 森永製菓株式会社 ポリフェノール類化合物の吸収促進用の医薬組成物、ポリフェノール類化合物を含有する飲食品又は飲食品素材の製造方法及びポリフェノール類化合物を含有する飲食品又は飲食品素材
EP2627326A2 (fr) * 2010-10-12 2013-08-21 Vifor SA Nouvelles compositions contenant des acides gras oméga-3 et oméga-6 et leurs utilisations
US20150164833A1 (en) * 2013-12-17 2015-06-18 Mead Johnson Nutrition Company Nutritional composition containing a neurologic component of ursolic acid and uses thereof
JP2017178914A (ja) 2016-03-31 2017-10-05 株式会社ニュートリション・アクト 脳機能改善及び向上のための組成物
JP2019064955A (ja) 2017-09-29 2019-04-25 金印株式会社 アミロイドβ耐性増強剤

Also Published As

Publication number Publication date
EP4084787A1 (fr) 2022-11-09
CN115066237A (zh) 2022-09-16
JP7655920B2 (ja) 2025-04-02
KR20220123272A (ko) 2022-09-06
MX2022008258A (es) 2022-08-11
BR112022013296A2 (pt) 2022-09-06
WO2021136848A1 (fr) 2021-07-08
AU2021204964A1 (en) 2022-07-07
JP2023510525A (ja) 2023-03-14

Similar Documents

Publication Publication Date Title
CO2022010461A2 (es) Composición para usar en el tratamiento de trastornos cognitivos
CL2021002099A1 (es) Combinación farmacéutica que comprende tno155 y ribociclib.
CO2019008087A2 (es) Método para modular la actividad de inflamasoma e inflamación en el pulmón
MX2021009562A (es) Combinacion farmaceutica que comprende tno155 y un inhibidor de pd-1.
CL2017001983A1 (es) Composiciones farmacéuticas para terapia combinada.
MX2018013240A (es) Composiciones antiirritantes sinergisticas de taurina y aloe.
MX2022012536A (es) Composiciones que comprenden polisacaridos sulfatados.
CL2019001658A1 (es) Derivados de la pirimidin enona tricíclica para la inhibición de rory y otros usos.
MX2020006001A (es) Composicion para el cuidado personal.
BR112021024109A2 (pt) Composições farmacêuticas compreendendo um agonista fxr e um fibrato para uso no tratamento de doença hepática colestática
BR112019018088A2 (pt) Composições propositadamente selecionadas que compreendem canabinoides purificados e/ou terpenos purificados
CL2022002833A1 (es) Anticuerpos anti-flt3 y composiciones
BR112022001968A2 (pt) Formulações que incluem di-hidrohonokiol
BR112018077350A2 (pt) composições de fosfolipídio
BR112022019432A2 (pt) Terapia de aumento mitocondrial
BR112022021402A2 (pt) Composição sinérgica para cuidados pessoais/preservante com um éster de poliglicerol
BR112023000333A2 (pt) Composição farmacêutica para o tratamento de vitiligo
BR112022022467A2 (pt) Composições para tratamento bucal que compreendem ácido dicarboxílico
CO2024017422A2 (es) Composiciones y métodos para inhibir la expresión de serina proteasa transmembrana 6 (tmprss6)
CL2019003011A1 (es) Composiciones para el cuidado bucal a base de oxido de cinc y fosfato de dihidrógeno de calcio.
BR112023025880A2 (pt) Formulação subcutânea e métodos para tratamento de edema refratário a diuréticos orais
BR112022015029A2 (pt) Formulações que fornecem desempenho de fragrância de longa de duração
MX2023007479A (es) Composiciones de cannabidiol y usos de las mismas.
BR112019003630A2 (pt) composição oleosa para metalurgia e método para metalurgia
BR112018071493A2 (pt) usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce